Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Income taxes (Tables)

v3.25.0.1
Income taxes (Tables)
 12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Income before Income Tax, Domestic and Foreign
The components of the loss before the provision for income taxes for the years ended December 31, 2022, 2023 and 2024 were as follows:
2022 2023 2024
Domestic $ (84,778) $ (31,021) $ (12,180)
Foreign 1,633  3,155  2,650 
Total loss before income taxes $ (83,145) $ (27,866) $ (9,530)
Schedule of Components of Income Tax Expense (Benefit)
The provision for income taxes for the years ended December 31, 2022, 2023 and 2024 was as follows:
2022 2023 2024
Current:
   Domestic
 $ 109  $ 56  $ 448 
   Foreign
 1,933  646  1,090 
Total current income tax expense 2,042  702  1,538 
Deferred:
   Domestic
 (24) (126) — 
   Foreign
 (1,502) 931  389 
Total deferred income tax expense (1,526) 805  389 
Total provision for income taxes $ 516  $ 1,507  $ 1,927 
Schedule of Effective Income Tax Rate Reconciliation
A reconciliation of the Company’s theoretical income tax expense to actual income tax expense for the years ended December 31, 2022, 2023 and 2024 is as follows:
2022 2023 2024
Tax Rate Tax Rate Tax Rate
Theoretical tax benefit $ (19,123) 23  % $ (6,409) 23  % $ (2,192) 23  %
Increase (decrease) in effective tax rate due to:
Change in valuation allowance 16,187  (20) % 3,498  (12) % (655) 7  %
Effect of entities with different tax rates 125  0  % 48  0  % 145  (2) %
Non-deductible expenses, net 3,442  (4) % 4,368  (16) % 4,455  (47) %
Income in zero tax rate (67) 0  % —  0  % —  0  %
Change in tax reserve for uncertain tax positions 12  0  % 145  (1) % 202  (2) %
Other (60) 0  % (143) 1  % (28) 1  %
Total effective income taxes $ 516  (1) % $ 1,507  (5) % $ 1,927  (20) %
Schedule of Deferred Tax Assets and Liabilities
The following table presents the significant components of the Company’s deferred tax assets and liabilities:
December 31,
2023 2024
Deferred tax assets:
Net operating loss carryforwards $ 60,582  $ 61,014 
Research and development expenses 12,000  11,028 
Lease liabilities 10,077  9,208 
Accruals and reserves 1,375  1,282 
Share-based compensation 668  401 
Deferred revenue 82  120 
Other 503  554 
Gross deferred tax assets 85,287  83,607 
Valuation allowance (73,960) (73,305)
Total deferred tax assets $ 11,327  $ 10,302 
Deferred tax liabilities:
Intangible assets (966) (977)
Deferred contract acquisition costs (3,123) (3,747)
Property and equipment (1,108) (683)
Right-of-use-assets (8,208) (7,945)
Other comprehensive income (201) (89)
Other (9) (137)
Gross deferred tax liabilities (13,615) (13,578)
Net deferred taxes $ (2,288) $ (3,276)
Schedule of Unrecognized Tax Benefits Roll Forward
The following table shows the changes in the gross amount of unrecognized tax positions as of December 31, 2022, 2023 and 2024.
Unrecognized tax
positions
Balance as of January 1, 2022 $ 403 
Increases related to current year tax positions 12 
Additions related to business combinations 193 
Balance as of December 31, 2022 608 
Increases related to current year tax positions 145 
Balance as of December 31, 2023 753 
Increases related to current year tax positions 202 
Additions related to business combinations — 
Balance as of December 31, 2024 $ 955